American Gene Engineer Corp (AGEC) SEC Filing 10-K Annual report for the fiscal year ending Friday, October 31, 2014

American Gene Engineer Corp

CIK: 1600784 Ticker: AGEC
Document and Entity Information (USD $)
12 Months Ended
Oct. 31, 2014
Jan. 28, 2015
Apr. 30, 2014
Document and Entity Information      
Entity Registrant Name AMERICAN GENE ENGINEER CORP    
Entity Central Index Key 0001600784    
Entity Filer Category Smaller Reporting Company    
Amendment Flag false    
Document Type 10-K    
Document Period End Date Oct. 31, 2014    
Document Fiscal Year Focus 2014    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --10-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Public Float     $ 2,148dei_EntityPublicFloat
Entity Common Stock, Shares Outstanding   100,000,000dei_EntityCommonStockSharesOutstanding  

View differences made from one year to another to evaluate American Gene Engineer Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Gene Engineer Corp.


Assess how American Gene Engineer Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Gene Engineer Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors